Jon Styf  |  April 2, 2024

Category: Legal News
Close up of oral medication solution being poured into a spoon, representing the vancomycin recall.
(Photo Credit: siam.pukkato/Shutterstock)

Vancomycin recall overview: 

  • Who: Anmeal Pharmaceuticals recalled four lots of its vancomycin hydrochloride for oral solution. 
  • Why: Bottles of the vancomycin hydrochloride were overfilled, leading to patients receiving a larger dose than prescribed.
  • Where: The vancomycin recall is effective across the United States.

Amneal Pharmaceuticals issued a vancomycin recall for four lots of its vancomycin hydrochloride for oral solution because the bottles were overfilled.

The vancomycin potency can lead to a higher dose than prescribed for patients. The issue occurred during the manual bottle filling stage.

The vancomycin orał recall includes lots 22613003A, 22613004A, 22613005A and 22613005B of the vancomycin solution with an expiration date of 09/2025 in 80 milliliter, 150 mL and 300 ml bottles. The lots were distributed between Nov. 9, 2023, and Feb. 20, 2024.

The highest recommended daily dose of the vancomycin oral solution is 2 grams per day, so patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency according to the recall.

Renal issues can lead to electrolyte abnormalities such as high potassium leading to cardiac arrest, the vancomycin recall says.

No reports of adverse effects from vancomycin recall, company says

Anmeal Pharmaceuticals says it has not received any reports of illness directly related to the recall so far. The company is not currently facing legal action over the recall, but Top Class Actions follows recalls closely as they sometimes lead to class action lawsuits.

Customers and retailers can contact Amneal by phone at 833-582-0812 between 8 a.m. and 5 p.m. ET, Monday through Friday, or by email at Vancomycin_Recall@amneal.com.

The FDA published two voluntary nationwide recalls in December 2022 for vancomycin and daptomycin injection products offered by Hospira Inc. and Accord Healthcare, respectively. 

Are you affected by the vancomycin recall? Let us know in the comments. 


Don’t Miss Out!

Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!


Read About More Class Action Lawsuits & Class Action Settlements:

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

18 thoughts onVancomycin recall issued due to potency issue

  1. richard cribari says:

    add me

  2. Ana says:

    Add me

  3. Pearl Reynolds says:

    Add My Name

  4. Alain Michael says:

    Add me please

  5. Jeffrey Souza says:

    please add me

  6. Khanh says:

    Add me

  7. Dennis N Sfeir says:

    Add me too.

  8. Talitha frazier says:

    Add me

  9. George Chiampas says:

    Add me

  10. darryl cromar says:

    add me

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.